Weihe Zhang

2.0k total citations
44 papers, 1.4k citations indexed

About

Weihe Zhang is a scholar working on Immunology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Weihe Zhang has authored 44 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 21 papers in Molecular Biology and 7 papers in Organic Chemistry. Recurrent topics in Weihe Zhang's work include Phagocytosis and Immune Regulation (20 papers), Cell death mechanisms and regulation (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Weihe Zhang is often cited by papers focused on Phagocytosis and Immune Regulation (20 papers), Cell death mechanisms and regulation (5 papers) and Metabolism, Diabetes, and Cancer (5 papers). Weihe Zhang collaborates with scholars based in United States, China and Poland. Weihe Zhang's co-authors include Yi Liu, Stephen C. Bergmeier, Xiaozhuo Chen, Yanyan Cao, Yanrong Qian, Lingying Tong, Robert A. Colvin, Juan Ding, Jennifer V. Hines and Huzoor Akbar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and The Journal of Immunology.

In The Last Decade

Weihe Zhang

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weihe Zhang United States 18 682 500 412 185 171 44 1.4k
Ho H. Lee New Zealand 21 741 1.1× 380 0.8× 397 1.0× 324 1.8× 397 2.3× 40 1.6k
Hariprasad Vankayalapati United States 21 1.5k 2.2× 227 0.5× 180 0.4× 257 1.4× 280 1.6× 61 2.2k
Belamy B. Cheung Australia 25 1.3k 1.9× 330 0.7× 582 1.4× 289 1.6× 92 0.5× 61 1.8k
Feifei Xu China 24 1.2k 1.7× 395 0.8× 352 0.9× 362 2.0× 65 0.4× 76 1.8k
Maria Serova France 27 1.0k 1.5× 428 0.9× 193 0.5× 552 3.0× 208 1.2× 60 1.7k
Xiaobing Deng United States 24 1.2k 1.8× 195 0.4× 300 0.7× 436 2.4× 138 0.8× 39 1.8k
Krikor Bijian Canada 22 553 0.8× 169 0.3× 166 0.4× 162 0.9× 122 0.7× 40 1.2k
Gennadi V. Glinsky United States 18 1.3k 1.9× 571 1.1× 261 0.6× 593 3.2× 86 0.5× 22 1.9k
Xiaonan Zhang Sweden 21 1.2k 1.7× 224 0.4× 383 0.9× 475 2.6× 156 0.9× 65 1.9k
Xiao Tan China 20 975 1.4× 191 0.4× 440 1.1× 222 1.2× 44 0.3× 53 1.4k

Countries citing papers authored by Weihe Zhang

Since Specialization
Citations

This map shows the geographic impact of Weihe Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihe Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihe Zhang more than expected).

Fields of papers citing papers by Weihe Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihe Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihe Zhang. The network helps show where Weihe Zhang may publish in the future.

Co-authorship network of co-authors of Weihe Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Weihe Zhang. A scholar is included among the top collaborators of Weihe Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihe Zhang. Weihe Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Kaixiang, Xia Yu, Lei Hua, et al.. (2025). Activation of the bacterial defense-associated sirtuin system. Communications Biology. 8(1). 297–297.
2.
3.
Zhang, Weihe, Xiaogang Cheng, Lakshminarayana Vogeti, et al.. (2022). Scaffold hopping via ring opening enables identification of acyclic compounds as new complement Factor D inhibitors. Bioorganic & Medicinal Chemistry. 74. 117034–117034. 4 indexed citations
4.
Kotian, Pravin L., Pengcheng Lu, Xilin Chen, et al.. (2021). Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE). Journal of Medicinal Chemistry. 64(17). 12453–12468. 22 indexed citations
5.
Zheng, Hongchao, Jichen Zhao, Bing Li, et al.. (2021). UNC5293, a potent, orally available and highly MERTK-selective inhibitor. European Journal of Medicinal Chemistry. 220. 113534–113534. 8 indexed citations
6.
Wang, Liyi, Weihe Zhang, Yi Liu, et al.. (2020). Isosteres of ester derived glucose uptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(18). 127406–127406. 6 indexed citations
7.
DeRyckere, Deborah, Alisa B. Lee‐Sherick, Amanda A. Hill, et al.. (2016). UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models. Clinical Cancer Research. 23(6). 1481–1492. 51 indexed citations
8.
Minson, Katherine A., Catherine C. Smith, Deborah DeRyckere, et al.. (2016). The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia. JCI Insight. 1(3). e85630–e85630. 61 indexed citations
9.
Wang, Xiaodong, Jing Liu, Weihe Zhang, et al.. (2016). Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase Inhibitors. ACS Medicinal Chemistry Letters. 7(12). 1044–1049. 24 indexed citations
10.
Cummings, Christopher T., Weihe Zhang, Kurtis D. Davies, et al.. (2015). Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status. Molecular Cancer Therapeutics. 14(9). 2014–2022. 50 indexed citations
11.
Zhang, Weihe, Xuecheng Chen, Tao Tang, & Ewa Mijowska. (2014). Superstable magnetic nanoreactors with high efficiency for Suzuki-coupling reactions. Nanoscale. 6(21). 12884–12889. 15 indexed citations
12.
Liu, Jing, Weihe Zhang, Michael A. Stashko, et al.. (2013). UNC1062, a new and potent Mer inhibitor. European Journal of Medicinal Chemistry. 65. 83–93. 55 indexed citations
13.
Zhang, Weihe, Dehui� Zhang, Michael A. Stashko, et al.. (2013). Pseudo-Cyclization through Intramolecular Hydrogen Bond Enables Discovery of Pyridine Substituted Pyrimidines as New Mer Kinase Inhibitors. Journal of Medicinal Chemistry. 56(23). 9683–9692. 55 indexed citations
14.
Zhang, Weihe, Andrew L. McIver, Michael A. Stashko, et al.. (2013). Discovery of Mer Specific Tyrosine Kinase Inhibitors for the Treatment and Prevention of Thrombosis. Journal of Medicinal Chemistry. 56(23). 9693–9700. 40 indexed citations
15.
Liu, Yi, Yanyan Cao, Weihe Zhang, et al.. (2012). A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo. Molecular Cancer Therapeutics. 11(8). 1672–1682. 444 indexed citations
16.
Zhang, Weihe. (2010). Design and Synthesis of Potential Anticancer Agents. OhioLink ETD Center (Ohio Library and Information Network). 1 indexed citations
17.
Zhang, Weihe, Yi Liu, Xiaozhuo Chen, & Stephen C. Bergmeier. (2010). Novel inhibitors of basal glucose transport as potential anticancer agents. Bioorganic & Medicinal Chemistry Letters. 20(7). 2191–2194. 61 indexed citations
18.
Liu, Yi, Weihe Zhang, Yanyan Cao, et al.. (2010). Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms. Cancer Letters. 298(2). 176–185. 72 indexed citations
19.
Cheung, Lawrence H., et al.. (2007). Improved expression of a soluble single chain antibody fusion protein containing tumor necrosis factor in Escherichia coli. Applied Microbiology and Biotechnology. 77(1). 99–106. 6 indexed citations
20.
Liu, Yuying, Weihe Zhang, Lawrence H. Cheung, et al.. (2006). The Antimelanoma Immunocytokine scFvMEL/TNF Shows Reduced Toxicity and Potent Antitumor Activity against Human Tumor Xenografts. Neoplasia. 8(5). 384–393. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ho H. Lee Breakdown of academic impact, for papers by Hariprasad Vankayalapati Breakdown of academic impact, for papers by Belamy B. Cheung Breakdown of academic impact, for papers by Feifei Xu Breakdown of academic impact, for papers by Maria Serova Breakdown of academic impact, for papers by Xiaobing Deng Breakdown of academic impact, for papers by Krikor Bijian Breakdown of academic impact, for papers by Gennadi V. Glinsky Breakdown of academic impact, for papers by Xiaonan Zhang Breakdown of academic impact, for papers by Xiao Tan
Rankless by CCL
2026